These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2715367)

  • 1. Propafenone disposition in renal insufficiency and renal failure.
    Burgess E; Duff H; Wilkes P
    J Clin Pharmacol; 1989 Feb; 29(2):112-3. PubMed ID: 2715367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolites.
    Fromm MF; Botsch S; Heinkele G; Evers J; Kroemer HK
    Eur J Clin Pharmacol; 1995; 48(3-4):279-83. PubMed ID: 7589055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis removal of propafenone.
    Burgess ED; Duff HJ
    Pharmacotherapy; 1989; 9(5):331-3. PubMed ID: 2813154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of famotidine in renal insufficiency.
    Halstenson CE; Abraham PA; Opsahl JA; Chremos AN; Keane WF; Matzke GR
    J Clin Pharmacol; 1987 Oct; 27(10):782-7. PubMed ID: 3429684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.
    Humbert G; Fillastre JP; Leroy A; Godin M; Van Winzum C
    Rev Infect Dis; 1979; 1(1):118-26. PubMed ID: 318213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.
    Juma FD; Rogers HJ; Trounce JR
    Eur J Clin Pharmacol; 1981; 19(6):443-51. PubMed ID: 7250178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Gehr TW; Rudy DW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):31-8. PubMed ID: 8033492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear kinetics of propafenone metabolites in healthy man.
    Vozeh S; Haefeli W; Ha HR; Vlcek J; Follath F
    Eur J Clin Pharmacol; 1990; 38(5):509-13. PubMed ID: 2379537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone disposition during continuous venovenous hemofiltration.
    Seto W; Trope AE; Gow RM
    Ann Pharmacother; 1999 Sep; 33(9):957-9. PubMed ID: 10492500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.